Thermo Fisher Scientific Q1 FY26: where the revenue came from and where it went
The whole income statement of Thermo Fisher Scientific for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jan 1 – Mar 28, 2026
- Reported
- May 1, 2026
Revenue$11.01B
+6% year over year
Gross profit$4.35B
40% margin
Operating profit$1.86B
17% margin
Net profit$1.65B
15% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 11.01 | 100% | +6% |
| Services | 4.73 | 43% | +8% |
| Consumables | 4.72 | 43% | +8% |
| Instruments | 1.56 | 14% | −4% |
| Cost of revenue | −6.66 | 60% | |
| Gross profit | 4.35 | 40% margin | +0pp |
| R&D | −0.34 | 3% | +0pp |
| SG&A | −2.15 | 20% | +0pp |
| Operating profit | 1.86 | 17% margin | +0pp |
| Interest & other costs | −0.14 | ||
| Tax | −0.07 | ||
| Net profit | 1.65 | 15% margin | +0pp |
214 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest